268 related articles for article (PubMed ID: 16622297)
21. 11β-Hydroxysteroid dehydrogenase type 1: potential therapeutic target for metabolic syndrome.
Joharapurkar A; Dhanesha N; Shah G; Kharul R; Jain M
Pharmacol Rep; 2012; 64(5):1055-65. PubMed ID: 23238463
[TBL] [Abstract][Full Text] [Related]
22. Acute in vivo regulation of 11beta-hydroxysteroid dehydrogenase type 1 activity by insulin and intralipid infusions in humans.
Wake DJ; Homer NZ; Andrew R; Walker BR
J Clin Endocrinol Metab; 2006 Nov; 91(11):4682-8. PubMed ID: 16954164
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target.
Wamil M; Seckl JR
Drug Discov Today; 2007 Jul; 12(13-14):504-20. PubMed ID: 17631244
[TBL] [Abstract][Full Text] [Related]
24. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.
Tomlinson JW; Walker EA; Bujalska IJ; Draper N; Lavery GG; Cooper MS; Hewison M; Stewart PM
Endocr Rev; 2004 Oct; 25(5):831-66. PubMed ID: 15466942
[TBL] [Abstract][Full Text] [Related]
25. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy.
Wang M
Handb Exp Pharmacol; 2011; (203):127-46. PubMed ID: 21484570
[TBL] [Abstract][Full Text] [Related]
26. The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans.
Andrew R; Westerbacka J; Wahren J; Yki-Järvinen H; Walker BR
Diabetes; 2005 May; 54(5):1364-70. PubMed ID: 15855321
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women.
Goedecke JH; Wake DJ; Levitt NS; Lambert EV; Collins MR; Morton NM; Andrew R; Seckl JR; Walker BR
Clin Endocrinol (Oxf); 2006 Jul; 65(1):81-7. PubMed ID: 16817824
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of 11β-hydroxysteroid dehydrogenase 1 by carbenoxolone affects glucose homeostasis and obesity in db/db mice.
Dhanesha N; Joharapurkar A; Shah G; Kshirsagar S; Dhote V; Sharma A; Jain M
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):69-77. PubMed ID: 22060140
[TBL] [Abstract][Full Text] [Related]
29. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y
Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364
[TBL] [Abstract][Full Text] [Related]
30. A polygenic model of the metabolic syndrome with reduced circulating and intra-adipose glucocorticoid action.
Morton NM; Densmore V; Wamil M; Ramage L; Nichol K; Bünger L; Seckl JR; Kenyon CJ
Diabetes; 2005 Dec; 54(12):3371-8. PubMed ID: 16306351
[TBL] [Abstract][Full Text] [Related]
31. Tissue-specific dysregulation of cortisol regeneration by 11βHSD1 in obesity: has it promised too much?
Stomby A; Andrew R; Walker BR; Olsson T
Diabetologia; 2014 Jun; 57(6):1100-10. PubMed ID: 24710966
[TBL] [Abstract][Full Text] [Related]
32. The role and regulation of 11β-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
Stimson RH; Walker BR
Horm Mol Biol Clin Investig; 2013 Sep; 15(2):37-48. PubMed ID: 25436731
[TBL] [Abstract][Full Text] [Related]
33. Ectopic lipid deposition mediates insulin resistance in adipose specific 11β-hydroxysteroid dehydrogenase type 1 transgenic mice.
Abulizi A; Camporez JP; Zhang D; Samuel VT; Shulman GI; Vatner DF
Metabolism; 2019 Apr; 93():1-9. PubMed ID: 30576689
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins.
Kannisto K; Pietiläinen KH; Ehrenborg E; Rissanen A; Kaprio J; Hamsten A; Yki-Järvinen H
J Clin Endocrinol Metab; 2004 Sep; 89(9):4414-21. PubMed ID: 15356040
[TBL] [Abstract][Full Text] [Related]
35. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
Harno E; Cottrell EC; Keevil BG; DeSchoolmeester J; Bohlooly-Y M; Andersén H; Turnbull AV; Leighton B; White A
Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological evaluation of adipose dysfunction via 11β-hydroxysteroid dehydrogenase type 1 in the development of diabetes in diet-induced obese mice with cortisone pellet implantation.
Akiyama N; Akiyama Y; Kato H; Kuroda T; Ono T; Imagawa K; Asakura K; Shinosaki T; Murayama T; Hanasaki K
J Pharmacol Exp Ther; 2014 Apr; 349(1):66-74. PubMed ID: 24511146
[TBL] [Abstract][Full Text] [Related]
37. Fructose, Glucocorticoids and Adipose Tissue: Implications for the Metabolic Syndrome.
Legeza B; Marcolongo P; Gamberucci A; Varga V; Bánhegyi G; Benedetti A; Odermatt A
Nutrients; 2017 Apr; 9(5):. PubMed ID: 28445389
[TBL] [Abstract][Full Text] [Related]
38. Physiological roles of 11 beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase.
White PC; Rogoff D; McMillan DR
Curr Opin Pediatr; 2008 Aug; 20(4):453-7. PubMed ID: 18622204
[TBL] [Abstract][Full Text] [Related]
39. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
Stewart PM; Toogood AA; Tomlinson JW
Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677
[TBL] [Abstract][Full Text] [Related]
40. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.
Stewart PM
Eur J Endocrinol; 2003 Sep; 149(3):163-8. PubMed ID: 12943516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
